Skip to content

Mecta-C Stand Alone Extension

by Medacta International S.A.

510(k) K203076

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK203076 Date6 Nov 2020ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
OVE
Device Class
Class II
Regulation
21 CFR Part 888.3080
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Mecta-C Stand Alone Extension is an orthopedic interbody fusion device designed for spinal stabilization. It combines a radiolucent interbody spacer with modular components to facilitate lumbar or cervical interbody fusion procedures, providing structural support and promoting bony fusion between vertebrae.

This device is supplied sterile and intended for single-use, featuring a modular design with eight configurable implant options to address specific anatomical needs. It is regulated under FDA 510(k) clearance (K203076) as a substantially equivalent orthopedic device, with no third-party review. Storage and handling must comply with sterile medical device protocols to ensure integrity prior to surgical use.

Other devices from Medacta International S.A.

See all devices from Medacta International S.A. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of spinal procedures is the Mecta-C Stand Alone Extension designed to support, and how does its modular design benefit the surgeon?

    The Mecta-C Stand Alone Extension is specifically designed for lumbar or cervical interbody fusion procedures, providing structural support to stabilize the spine and promote bony fusion between vertebrae. Its modular design offers eight configurable implant options, allowing surgeons to select the best fit for individual anatomical needs, ensuring a tailored approach to spinal stabilization.

  • Is the Mecta-C Stand Alone Extension reusable, or is it intended for single-use only? How should it be handled to maintain sterility?

    The Mecta-C Stand Alone Extension is intended for single-use only and is supplied sterile. To preserve sterility before surgical use, it must be stored and handled according to standard sterile medical device protocols, ensuring its integrity remains uncompromised until implantation.

  • What regulatory pathway was followed for FDA clearance of this device, and what does the ‘substantially equivalent’ designation mean in this context?

    The Mecta-C Stand Alone Extension received FDA 510(k) clearance (K203076) under a *Special* clearance type, classified under the *Orthopedic* advisory committee (OR). The ‘substantially equivalent’ designation (decision_code: SESE) means the FDA determined it is as safe and effective as a legally marketed device that served as its predicate, without requiring third-party review.

  • How should the device be stored, and are there any specific instructions related to its packaging or shelf life?

    While the provided data does not specify shelf life, the device must be stored and handled in compliance with sterile medical device protocols to maintain its integrity. The sterile packaging should remain unopened until immediate preoperative use, and any storage conditions should align with manufacturer-recommended practices for orthopedic implants.